We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

Smith & Nephew PLC settlement illustrates pitfalls of ignoring red flags

  • Jenner & Block
  • -
  • Greece, United Kingdom, USA
  • -
  • April 30 2012

A London-based medical device company, Smith & Nephew PLC, has settled an FCPA matter with DOJ and SEC involving bribes to public sector doctors in Greece by U.S. and German subsidiaries of Smith & Nephew

Tenet pays $42 million to settle False Claim Act lawsuit

  • Jenner & Block
  • -
  • USA
  • -
  • April 30 2012

On April 10, 2012, the Department of Justice announced that Tenet Healthcare Corporation agreed to pay $42.75 million to settle a False Claim Act lawsuit involving Medicare overbilling claims

Medical device maker pays $17 million to settle FCPA allegations

  • Jenner & Block
  • -
  • USA
  • -
  • April 30 2012

On March 26, 2012, the U.S. Department of Justice announced that Biomet, Inc., a medical device maker, agreed to pay a $17.28 million criminal penalty and enter into a three year deferred prosecution agreement to settle several claims brought under the Foreign Corrupt Practices Act,15 U.S.C. 78dd-1, et seq

Medical device company settlement highlights internal audit failures

  • Jenner & Block
  • -
  • USA
  • -
  • April 30 2012

Biomet Inc., a medical device company based in Indiana, has settled FCPA enforcement actions with the DOJ and SEC in connection with alleged improper payments by its subsidiaries and distributors to public doctors in Argentina, Brazil, and China

Medical device company Biomet Inc. settlement highlights internal audit failures

  • Jenner & Block
  • -
  • USA
  • -
  • April 17 2012

Biomet Inc. (“Biomet”), a medical device company based in Indiana, has settled FCPA enforcement actions with the DOJ and SEC in connection with alleged improper payments by its subsidiaries and distributors to public doctors in Argentina, Brazil, and China

“The elephant in the room”: indictment of former GlaxoSmithKline in-house attorney dismissed due to prosecutors’ misstatement of advice of counsel defense to grand jurors

  • Jenner & Block
  • -
  • USA
  • -
  • March 24 2011

A federal district court has dismissed the indictment of a former in-house counsel at pharmaceutical company GlaxoSmithKline ("GSK"), Lauren Stevens, who was charged in November 2010 with obstruction of a proceeding, false statements, and falsifying or concealing documents, for her role in responding to a document request from the Food and Drug Administration ("FDA"

Indictment of former GlaxoSmithKline in-house attorney highlights risks and provides lessons for handling document requests in government investigations

  • Jenner & Block
  • -
  • USA
  • -
  • November 23 2010

A former in-house counsel at pharmaceutical company GlaxoSmithKline ("GSK"), Lauren Stevens, was indicted earlier this month for obstruction of a proceeding, false statements, and falsifying or concealing documents for her role in responding to a document request from the Food and Drug Administration ("FDA"